Cargando…

P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)

Detalles Bibliográficos
Autores principales: Dragičević, Ida Hude, Bašić-Kinda, Sandra, Dujmović, Dino, Radman, Ivo, Dreta, Barbara, Dotlić, Sandra, Galunić-Bilić, Lea, Dobrenić, Margareta, Kralik, Marko, Rončević, Pavle, Aurer, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621567/
http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb
_version_ 1784821587464159232
author Dragičević, Ida Hude
Bašić-Kinda, Sandra
Dujmović, Dino
Radman, Ivo
Dreta, Barbara
Dotlić, Sandra
Galunić-Bilić, Lea
Dobrenić, Margareta
Kralik, Marko
Rončević, Pavle
Aurer, Igor
author_facet Dragičević, Ida Hude
Bašić-Kinda, Sandra
Dujmović, Dino
Radman, Ivo
Dreta, Barbara
Dotlić, Sandra
Galunić-Bilić, Lea
Dobrenić, Margareta
Kralik, Marko
Rončević, Pavle
Aurer, Igor
author_sort Dragičević, Ida Hude
collection PubMed
description
format Online
Article
Text
id pubmed-9621567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96215672022-11-01 P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) Dragičević, Ida Hude Bašić-Kinda, Sandra Dujmović, Dino Radman, Ivo Dreta, Barbara Dotlić, Sandra Galunić-Bilić, Lea Dobrenić, Margareta Kralik, Marko Rončević, Pavle Aurer, Igor Hemasphere Advanced Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621567/ http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Advanced Stages
Dragičević, Ida Hude
Bašić-Kinda, Sandra
Dujmović, Dino
Radman, Ivo
Dreta, Barbara
Dotlić, Sandra
Galunić-Bilić, Lea
Dobrenić, Margareta
Kralik, Marko
Rončević, Pavle
Aurer, Igor
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title_full P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title_fullStr P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title_full_unstemmed P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title_short P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
title_sort p016: reduced steroid exposure is safe and does not reduce disease control among hodgkin lymphoma patients treated with escalated beacopp (ebeacopp)
topic Advanced Stages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621567/
http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb
work_keys_str_mv AT dragicevicidahude p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT basickindasandra p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT dujmovicdino p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT radmanivo p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT dretabarbara p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT dotlicsandra p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT galunicbiliclea p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT dobrenicmargareta p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT kralikmarko p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT roncevicpavle p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp
AT aurerigor p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp